ConductScience.org, home

Paper21396841

Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.

Yin B and 5 others. Urol Oncol, 2012. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder. Papers, record 21396841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21396841

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
PubMed
Journal
Urol Oncol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2012-12-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yin BBo
2Liu GGang
3Wang XSXiao-Song
4Zhang HHui
5Song YSYong-Sheng
6Wu BBin

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Transitional CellMajor topic
Neoplasm ProteinsMajor topic
Urinary Bladder NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Blotting, Western
Female
Humans
Immunohistochemistry
Male
Middle Aged
RNA, Messenger
Reverse Transcriptase Polymerase Chain Reaction
Transcriptome
Young Adult

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
31980914First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.Cancer Immunol Immunother2020https://conductscience.org/library/papers/31980914PubMed
31485721Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder.Virchows Arch2020https://conductscience.org/library/papers/31485721PubMed
30877975Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects.Transl Oncol2019https://conductscience.org/library/papers/30877975PubMed
30790015Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.Cancer Immunol Immunother2019https://conductscience.org/library/papers/30790015PubMed
29058301Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.Pathol Oncol Res2019https://conductscience.org/library/papers/29058301PubMed
28638445Association of MAGE A1-6 Expression with Lung Cancer Progression.J Cancer2017https://conductscience.org/library/papers/28638445PubMed
27895724Expression profile of SPACA5/Spaca5 in spermatogenesis and transitional cell carcinoma of the bladder.Oncol Lett2016https://conductscience.org/library/papers/27895724PubMed
26695143Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.Tumour Biol2016https://conductscience.org/library/papers/26695143PubMed
26464715Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26464715PubMed
25120790Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.Int J Clin Exp Pathol2014https://conductscience.org/library/papers/25120790PubMed
25031712MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells.Int J Clin Exp Pathol2014https://conductscience.org/library/papers/25031712PubMed
24349057Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma.PLoS One2013https://conductscience.org/library/papers/24349057PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
CTAGE164693PubTator's text mininghttps://conductscience.org/library/genes/64693NCBI Gene
MAGEA14100PubTator's text mininghttps://conductscience.org/library/genes/4100NCBI Gene
MAGEA124111PubTator's text mininghttps://conductscience.org/library/genes/4111NCBI Gene
MAGEA34102PubTator's text mininghttps://conductscience.org/library/genes/4102NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21396841

GET https://conductscience.org/api/papers/v1/21396841/authors